Available datapackage for study 'A Phase 3 Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Subjects Greater Than or Equal to 6 to Less Than 12 Years of Age'

Name: Available datapackage for study 'A Phase 3 Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Subjects Greater Than or Equal to 6 to Less Than 12 Years of Age'
Creator: Vivli
Published: 2025-09-25 13:40:39
License: 暂无描述

DataCite Commons2025-09-25 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008741.0

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the efficacy and safety of ustekinumab in pediatric participants aged greater than or equal to (>=) 6 through less than (<) 12 years with moderate to severe chronic plaque psoriasis

提供机构：

Vivli

创建时间：

2025-09-25